Free tool
FAERS Monitor: Piperacillin and Tazobactam and Sodium Chloride In Duplex Container
Last checked: Nov 20, 2026Source: FDA FAERS (openFDA)Methods & limitations
Reports naming NDA 206056 or its brand name (Piperacillin and Tazobactam and Sodium Chloride In Duplex Container, Piperacillin Sodium, Tazobactam Sodium). Reports on generic versions are filed under their own applications.
Reports
0
Serious
0
Hospitalization
0
Death reported
0
Any cause; not necessarily from the drug
No FAERS reports match. Try the generic name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.